Strong impact of MammaPrint and BluePrint on treatment decisions in luminal early breast cancer: results of the WSG-PRIMe study.
Breast Cancer Res Treat
; 175(2): 389-399, 2019 Jun.
Article
in En
| MEDLINE
| ID: mdl-30796651
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Chemotherapy, Adjuvant
/
Transcriptome
Type of study:
Clinical_trials
/
Guideline
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Breast Cancer Res Treat
Year:
2019
Type:
Article
Affiliation country:
Germany